Keyphrases
Brain Glioma
28%
Gene Isoforms
28%
CRISPR Interference (CRISPRi)
28%
Deconvolution Visualization
28%
Tumor Samples
28%
DNA Methylation Data
28%
Deconvolution
28%
Reference Deconvolution
28%
Complex DNA Mixtures
28%
Process Outcomes
28%
MiRNome
28%
Cancer Omics Data
28%
Heterogeneous Tumors
28%
Orthotopic Xenograft
28%
Patient-derived Organoids
28%
Health Avatar
28%
Cytokine Stimulation
28%
Tumor
28%
Transcriptome
28%
International Cooperative Ataxia Rating Scale (ICARS)
23%
Bulk Samples
23%
Technical Bias
21%
Deconvolution Method
18%
Zinc Finger
18%
Parallel Technique
14%
Patient Classification
14%
Biological Knowledge
14%
Publicly Available Data
14%
Feature Selection Methods
14%
Cancer Diagnosis
14%
Bulk Tissue
14%
Massive Parallelism
14%
Tissue Analysis
14%
Cell Subtypes
14%
Cell Signaling Networks
14%
Neoplastic Cells
14%
High Fold
14%
Transcriptomic Response
14%
Skin Tissue
14%
Stromal Cells
14%
Cell Population
14%
Bulk Transcriptome
14%
Cellular Level
14%
Clinical Issues
14%
Microarray
14%
Research Discovery
14%
Expression Data
14%
Non-small Cell Lung Cancer (NSCLC)
14%
Cancer Patients
14%
Exon Junction
14%
Gene Expression
14%
Therapeutic Target
14%
High-throughput Genetic Screen
9%
CRISPR-associated Protein 9
9%
Genotype Interactions
9%
Pooled Screening
9%
Data-driven Methods
9%
Three-stage Protocol
9%
Tumor-infiltrating Immune Cells
9%
Technology-based
9%
Available Technology
9%
Coding RNA
9%
Data Preparation
9%
MiRNA Target Genes
9%
Methylation
9%
Nuclear Localization
9%
Clinical Parameters
9%
Network Datasets
9%
Targetome
9%
PIWI-interacting RNA (piRNA)
9%
Transcriptome-wide
9%
Stromal Tumor
9%
Lung Cancer
9%
NrCAM
9%
Target Gene Prediction
9%
Biological Validation
9%
COL6A2
9%
Complex Samples
9%
Surgical Mask
9%
Feature Selection
9%
Human Development
9%
Human Disease
9%
Data Preprocessing
9%
Graphical User Interface
9%
Cancer Genome Atlas
9%
DNA Methylation Profile
9%
Methylome
9%
DNA Methylation Profiling
9%
Biological Inference
9%
Complex Cell
9%
DNA Methylome
9%
Methylation Changes
9%
Multiple Tissues
9%
Patient Cohort
9%
Cell Mixture
9%
R Shiny
9%
Multiple Parameters
9%
Confounder Adjustment
9%
Cellular Heterogeneity
9%
Harmonized Approach
9%
Cyclin-dependent Kinase 4 (CDK4)
9%
Specific Vulnerability
9%
DNA Repair Pathways
9%
Group-specific
9%
Genotoxic Damage
9%
Cell Cycle Machinery
9%
Genotoxic Agents
9%
Inefficacy
9%
Pathway Knowledge
9%
Matrix Factorization
7%
Factorization Method
7%
Different Datasets
7%
Patient Characteristics
7%
Clinically Meaningful Outcomes
7%
Tumor Biology
7%
Signal Deconvolution
7%
Biological Cells
7%
Risk Score
7%
Unsupervised Method
7%
Mutual Dependence
7%
Parallel Consensus
7%
Cancer Subtypes
7%
Primary Control
7%
Biochemistry, Genetics and Molecular Biology
Transcriptome
100%
Messenger RNA
43%
MicroRNA
37%
Tamsulosin
37%
Gene Expression
37%
Transcriptomics
30%
Gene Expression Profiling
28%
RNA
28%
RNA Interference
28%
STAT1
28%
Biological Phenomena and Functions Concerning the Entire Organism
28%
STAT3
28%
CRISPR
28%
Zinc Finger Motif
28%
Cytokine
28%
Epidermal Growth Factor Receptor
28%
Stromal Cell
28%
Feature Extraction
28%
Exon
28%
Isoform
28%
Patient Coding
28%
Promoter Region
23%
Genetics
18%
IDH1
18%
Nuclear Protein
14%
Protein Complexes
14%
Genetic Transcription
14%
Blood Brain Barrier
14%
COL6A2
14%
Essential Gene
14%
Immunocompetent Cell
9%
Genotyping
9%
Vascularization
9%
Platelet Derived Growth Factor Receptor Alpha
9%
Candidate Gene
9%
CRISPR/Cas9
9%
Clinical Trial
9%
Epigenetics
9%
Alpha Thalassemia/Mental Retardation X-Linked
9%
Genetic Screen
9%
Biological Functions
9%
Clonal Evolution
9%
Drug Response
9%
Angiogenesis
9%
Cell Proliferation
9%
Gene Function
9%
Immune Response
9%
Cyclin-Dependent Kinase
9%
Cancer Model
9%
Cyclin Dependent Kinase Inhibitor 2A
9%
Piwi-Interacting RNA
7%
Non-Coding RNA
7%
Methylome
5%
Dimensionality Reduction
5%
Principal Component Analysis
5%
Proteome
5%
Colon
5%
Complex System
5%
Functional Magnetic Resonance Imaging
5%
Medicine and Dentistry
Glioblastoma
59%
Ganglioglioma
28%
Organoid
28%
Xenograft
28%
Synapsin II
28%
Gene Expression Profiling
28%
Neoplasm
28%
DNA Repair
28%
Cell Cycle
28%
DNA A
28%
Temozolomide
21%
Gene Expression
21%
Radiation Therapy
21%
DNA Damage Response
14%
Biopsy Technique
14%
Alkylating Antineoplastic Agent
10%
Tumor Recurrence
10%
Primary Tumor
10%
Epidermal Growth Factor Receptor
10%
Promoter Region
9%
Progression Free Survival
7%
Recurrent Disease
7%
Cell DNA
7%
Nuclear Protein
5%
Tumor Cell
5%
Blood Brain Barrier
5%
Genetic Transcription
5%
Tumor Invasion
5%
Cellular Model
5%
Intracranial Tumor
5%
Systemic Therapy
5%
Protein Complex
5%